Covered recipient · General Payments record
DYLAN EDWARD POCHE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$2,407.60
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,500.00 | 1 |
| Food and Beverage | $314.53 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,500.00 | 1 |
| ABBVIE INC. | $171.53 | 11 |
| Lilly USA, LLC | $63.44 | 4 |
| Abbott Laboratories | $31.17 | 2 |
| Novo Nordisk AS | $29.01 | 2 |
| Phathom Pharmaceuticals, Inc. | $19.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (21)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.71 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124837904 | CMS |
| Abbott Laboratories | $16.46 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124837908 | CMS |
| ABBVIE INC. | $6.72 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282050 | CMS |
| ABBVIE INC. | $15.76 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282054 | CMS |
| ABBVIE INC. | $19.67 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282058 | CMS |
| ABBVIE INC. | $19.74 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282062 | CMS |
| ABBVIE INC. | $21.82 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282066 | CMS |
| ABBVIE INC. | $9.87 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282070 | CMS |
| ABBVIE INC. | $16.89 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282074 | CMS |
| ABBVIE INC. | $23.27 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282078 | CMS |
| ABBVIE INC. | $7.59 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282082 | CMS |
| ABBVIE INC. | $15.66 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282086 | CMS |
| ABBVIE INC. | $14.54 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105282090 | CMS |
| Lilly USA, LLC | $14.28 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136151991 | CMS |
| Lilly USA, LLC | $15.38 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136163612 | CMS |
| Lilly USA, LLC | $19.11 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136163920 | CMS |
| Lilly USA, LLC | $14.67 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136145143 | CMS |
| Novo Nordisk Inc | $15.37 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097763959 | CMS |
| Novo Nordisk Inc | $13.64 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097820064 | CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,500.00 | 10/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1118839085 | CMS |
| Phathom Pharmaceuticals, Inc. | $19.38 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151111114 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.